相似文献
1
Gene expression profiling and DNA methylation analyses of CTCs.
Mol Oncol. 2016 Mar;10(3):431-42. doi: 10.1016/j.molonc.2016.01.011. Epub 2016 Feb 5.
2
DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells.
Clin Chem. 2011 Aug;57(8):1169-77. doi: 10.1373/clinchem.2011.165902. Epub 2011 Jun 23.
3
Multiplex Gene Expression Profiling of In Vivo Isolated Circulating Tumor Cells in High-Risk Prostate Cancer Patients.
Clin Chem. 2018 Feb;64(2):297-306. doi: 10.1373/clinchem.2017.275503. Epub 2017 Nov 9.
4
Multigene reverse transcription-PCR profiling of circulating tumor cells in hormone-refractory prostate cancer.
Clin Chem. 2004 May;50(5):826-35. doi: 10.1373/clinchem.2003.028563. Epub 2004 Feb 26.
5
Molecular characterization of circulating tumor cells in breast cancer by a liquid bead array hybridization assay.
Clin Chem. 2011 Mar;57(3):421-30. doi: 10.1373/clinchem.2010.154328. Epub 2011 Jan 18.
6
Sample-to-Answer Isolation and mRNA Profiling of Circulating Tumor Cells.
Anal Chem. 2015 Jun 16;87(12):6258-64. doi: 10.1021/acs.analchem.5b01019. Epub 2015 Jun 2.
7
Direct comparison of size-dependent versus EpCAM-dependent CTC enrichment at the gene expression and DNA methylation level in head and neck squamous cell carcinoma.
Sci Rep. 2020 Apr 16;10(1):6551. doi: 10.1038/s41598-020-63055-y.
8
Direct Comparison of Metastasis-Related miRNAs Expression Levels in Circulating Tumor Cells, Corresponding Plasma, and Primary Tumors of Breast Cancer Patients.
Clin Chem. 2016 Jul;62(7):1002-11. doi: 10.1373/clinchem.2015.253716. Epub 2016 May 19.
9
Genomic high-resolution profiling of single CKpos/CD45neg flow-sorting purified circulating tumor cells from patients with metastatic breast cancer.
Clin Chem. 2014 Oct;60(10):1290-7. doi: 10.1373/clinchem.2014.222331.
10
Development of a molecular multimarker assay for the analysis of circulating tumor cells in adenocarcinoma patients.
Clin Lab. 2012;58(5-6):373-84.
引用本文的文献
1
Liquid biopsy for Renal Cell Carcinoma: A comprehensive review of techniques, applications, and future prospects.
Kidney Cancer. 2024 Feb;8(1):205-225. doi: 10.1177/24684570241303346. Epub 2024 Dec 24.
2
Recent Advances in Methods for Circulating Tumor Cell Detection.
Int J Mol Sci. 2023 Feb 15;24(4):3902. doi: 10.3390/ijms24043902.
3
Liquid Biopsy in Cancer: Focus on Lymphoproliferative Disorders.
Cancers (Basel). 2022 Oct 31;14(21):5378. doi: 10.3390/cancers14215378.
4
Liquid biopsies in myeloid malignancies.
Cancer Drug Resist. 2019 Dec 19;2(4):1044-1061. doi: 10.20517/cdr.2019.88. eCollection 2019.
5
DNA methylation analysis of tumor suppressor genes in liquid biopsy components of early stage NSCLC: a promising tool for early detection.
Clin Epigenetics. 2022 May 10;14(1):61. doi: 10.1186/s13148-022-01283-x.
6
DNA Methylation Analysis in Plasma Cell-Free DNA and Paired CTCs of NSCLC Patients before and after Osimertinib Treatment.
Cancers (Basel). 2021 Nov 27;13(23):5974. doi: 10.3390/cancers13235974.
7
Detection of VAR2CSA-Captured Colorectal Cancer Cells from Blood Samples by Real-Time Reverse Transcription PCR.
Cancers (Basel). 2021 Nov 23;13(23):5881. doi: 10.3390/cancers13235881.
8
Diagnostic performance of SHOX2 promoter methylation as biomarker for lung cancer identification: A meta-analysis update.
Thorac Cancer. 2021 Dec;12(24):3327-3332. doi: 10.1111/1759-7714.14206. Epub 2021 Nov 5.
9
Detection and relevance of epigenetic markers on ctDNA: recent advances and future outlook.
Mol Oncol. 2021 Jun;15(6):1683-1700. doi: 10.1002/1878-0261.12978. Epub 2021 May 14.
10
RNA-Based CTC Analysis Provides Prognostic Information in Metastatic Breast Cancer.
Diagnostics (Basel). 2021 Mar 14;11(3):513. doi: 10.3390/diagnostics11030513.
本文引用的文献
1
Single circulating tumor cell sequencing as an advanced tool in cancer management.
Expert Rev Mol Diagn. 2016;16(1):51-63. doi: 10.1586/14737159.2016.1116942. Epub 2015 Nov 26.
2
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.
Nature. 2015 Nov 26;527(7579):525-530. doi: 10.1038/nature16064. Epub 2015 Nov 11.
3
Clinical Relevance of Androgen Receptor Splice Variants in Castration-Resistant Prostate Cancer.
Curr Treat Options Oncol. 2015 Dec;16(12):57. doi: 10.1007/s11864-015-0375-z.
4
Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility.
Clin Cancer Res. 2015 Nov 1;21(21):4786-800. doi: 10.1158/1078-0432.CCR-14-1190.
5
Characterization of DNA Methylation in Circulating Tumor Cells.
Genes (Basel). 2015 Oct 21;6(4):1053-75. doi: 10.3390/genes6041053.
6
RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance.
Science. 2015 Sep 18;349(6254):1351-6. doi: 10.1126/science.aab0917.
7
Detection and Characterization of Circulating Tumor Cells by the CellSearch Approach.
Methods Mol Biol. 2015;1347:263-78. doi: 10.1007/978-1-4939-2990-0_18.
8
Sample Preparation Methods Following CellSearch Approach Compatible of Single-Cell Whole-Genome Amplification: An Overview.
Methods Mol Biol. 2015;1347:57-67. doi: 10.1007/978-1-4939-2990-0_4.
9
An optimised direct lysis method for gene expression studies on low cell numbers.
Sci Rep. 2015 Aug 5;5:12859. doi: 10.1038/srep12859.
10
Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor Cells.
Eur Urol. 2015 Dec;68(6):939-45. doi: 10.1016/j.eururo.2015.07.007. Epub 2015 Jul 15.
Zotero 插件